<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="pmc-domain-id">1931</journal-id><journal-id journal-id-type="pmc-domain">ijbms</journal-id><journal-id journal-id-type="publisher-id">IJBMS</journal-id><journal-title-group><journal-title>Iranian Journal of Basic Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">2008-3866</issn><issn pub-type="epub">2008-3874</issn><publisher><publisher-name>Mashhad University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4016687</article-id><article-id pub-id-type="pmcid-ver">PMC4016687.1</article-id><article-id pub-id-type="pmcaid">4016687</article-id><article-id pub-id-type="pmcaiid">4016687</article-id><article-id pub-id-type="pmid">24847419</article-id><article-id pub-id-type="publisher-id">ijbms-17-172</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>
<italic toggle="yes">In silico</italic> analysis of chimeric TF, Omp31 and BP26 fragments of <italic toggle="yes">Brucella melitensis</italic> for development of a multi subunit vaccine candidate</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ghasemi</surname><given-names initials="A">Amir</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ranjbar</surname><given-names initials="R">Reza</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Amani</surname><given-names initials="J">Jafar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</aff><aff id="aff2"><label>2</label>Applied Microbiology Research Center, Baqiyatallah Medical Science University, Tehran, Iran</aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author: Jafar Amani. Applied Microbiology Research Center, Baqiyatallah Medical Science University, Tehran, Iran. Vanak Sq. Molasadra St. Tehran, Iran. Tel: +98-21-82482568; Fax: +98-21-88068924. email: Jafar.amani@gmail.com</corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2014</year></pub-date><volume>17</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">237534</issue-id><fpage>172</fpage><lpage>180</lpage><history><date date-type="received"><day>2</day><month>6</month><year>2013</year></date><date date-type="accepted"><day>28</day><month>10</month><year>2013</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2014</year></date></event><event event-type="pmc-live"><date><day>20</day><month>05</month><year>2014</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2014-05-24 00:38:06.750"><day>24</day><month>05</month><year>2014</year></date></event></pub-history><permissions><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ijbms-17-172.pdf"/><abstract><p>
<bold><italic toggle="yes">Objective(s):</italic></bold> Brucellosis, especially caused by <italic toggle="yes">Brucella melitensis</italic>, remains one of the most common zoonotic diseases worldwide with more than 500,000 human cases reported annually. The commonly used live attenuated vaccine in ovine brucellosis prophylaxis is <italic toggle="yes">B. melitensis</italic> Rev1. But due to different problems caused by the administration of this vaccine, a protective subunit vaccine against <italic toggle="yes">B. melitensis</italic> is strongly demanded. <italic toggle="yes">Brucella</italic> BP26, Omp31 and TF proteins have shown a considerable potential as protective antigens for brucellosis. Chimeric proteins carrying epitopes or adjuvant sequences increase the possibility of eliciting a broad cellular or humoral immune response. <italic toggle="yes">In silico</italic> tools are highly suited to study, design and evaluate vaccine strategies.</p><p>
<bold><italic toggle="yes">Materials and Methods: </italic></bold>In this study, a synthetic chimeric gene, encoding TF, BP26 <sup>93-111</sup> and Omp31<sup>48-74 </sup>was designed. In order to predict the 3D structure of protein, modeling was carried out. </p><p>
<bold><italic toggle="yes">Results:</italic></bold> Validation results showed that 91.1% of residues lie in favored or additional allowed region of Ramachandran plot. The epitopes in the chimeric protein are likely to induce both the B-cell and T-cell mediated immune responses. </p><p>
<bold><italic toggle="yes">Conclusion</italic></bold>
<bold>:</bold> The chimeric protein may be used as multi subunit for development of <italic toggle="yes">Brucella</italic> vaccine candidates.</p></abstract><kwd-group><title>Key Words</title><kwd>Brucellosis</kwd><kwd>Chimeric protein</kwd><kwd>Epitope</kwd><kwd>Vaccination</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>
<italic toggle="yes">Brucella</italic> spp. are Gram-negative and facultative intracellular bacteria which cause brucellosis, a worldwide zoonotic disease leading to abortion in domestic animals and Malta fever in humans (<xref rid="B1" ref-type="bibr">1</xref>). <italic toggle="yes">Brucella melitensis </italic>Rev1 is an attenuated smooth strain used to control <italic toggle="yes">B. melitensis </italic>infection, which induces heterologous protection against other<italic toggle="yes"> Brucella </italic>spp<italic toggle="yes">. </italic>and is currently considered as the best vaccine for prophylaxis against ovine brucellosis (<xref rid="B2" ref-type="bibr">2</xref>). However, due to different problems caused by administration of live attenuated vaccines, a subunit vaccine that is protective against <italic toggle="yes">B. melitensis</italic> is desirable (<xref rid="B3" ref-type="bibr">3</xref>). There is an increasing interest in the study of immunogenicity and protective effects of outer membrane proteins (OMPs) of <italic toggle="yes">Brucella</italic> and cytoplasmic proteins (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). TF protein, 485 aa, is a cytoplasmic protein which has also been reported to act as a protective and a good immunogenic antigen (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>)<italic toggle="yes">.</italic> BP26 protein, a periplasmic protein, has previously been identified as an immunodominant antigen of the cytosoluble protein extract of <italic toggle="yes">Brucella</italic> in infected cattle, sheep, goats and humans (<xref rid="B8" ref-type="bibr">8</xref>). It has been reported that BP26 is a protective antigen (<xref rid="B6" ref-type="bibr">6</xref>). Recently, good reactivity of two linear epitope peptides of BP26 (position 93 to 101 and 104 to 111) with 137 <italic toggle="yes">Brucella</italic> infected sheep sera by ELISA has been shown (<xref rid="B9" ref-type="bibr">9</xref>). The OMPs of <italic toggle="yes">Brucella </italic>spp. have been characterized as potential immunogenic and protective antigen (Ag) (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). It has been shown that immunization with a peptide that contains amino acids 48 to 74 of Omp31 in adjuvant did not elicit a specific humoral response but elicited a Th1 response mediated by CD4+ T-cells. The peptide in adjuvant also induced levels of protection similar to those induced by rOmp31 against <italic toggle="yes">B. melitensis. </italic>However, it has been shown that recombinant antigens as protective Ags in animal models (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B6" ref-type="bibr">6</xref>, -) are not called protective response per se, suggesting multi subunit approach should be considered to optimize the immune response. By combining multiple antigens into a single vaccine, broad-spectrum protective immunity against many different clinical isolates has been achieved (<xref rid="B21" ref-type="bibr">21</xref>).</p><p>In this study, we designed a new structural model containing three putative antigenic determinants of TF, BP26 <sup>93-111</sup> and Omp31<sup>48-74</sup>, fused together by hydrophobic linkers. Restriction enzyme sites at 5&#8217; and 3&#8217; ends were added respectively, and codon of this chimeric gene for expression in bacteria was optimized to improve the efficiency of transcription and translation. Finally, a novel <italic toggle="yes">in silico </italic>approach was used to analysis the structure of the designed chimeric protein.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><p>
<bold><italic toggle="yes">Sequence analysis</italic></bold>
</p><p>Sequences of antigens were obtained from GeneBank. In order to identify a fragment common among all sequences, multiple sequence alignments were performed using ClustalW software (http://www.ebi.ac.uk/Tools/clustalw2). A chimeric sequence was constructed by fusing the C terminal of TF, N-terminal of Omp31<sup>48-74</sup> and middle fragment of BP26<sup>93-111</sup> using hydrophobic amino acid linkers (<xref rid="B22" ref-type="bibr">22</xref>). Stand-alone Leto gene optimization software (www.entelechon.com), OPTIMIZER server (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>), Kazusa codon usage database (http://www.kazusa.or.-jp/codon) and Swissprot reverse translation online tool (http://www.bioinformatics.org/sms2/rev_trans.html) were used for the <italic toggle="yes">in silico</italic> gene analysis and optimization of the chimeric gene. The chimeric gene was designed for cloning and expression in <italic toggle="yes">Escherichia coli</italic> (<xref rid="B25" ref-type="bibr">25</xref>). VaxiJen server was used to predict the immunogenicity of the whole antigen and its subunit vaccine (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>).</p><p>
<bold><italic toggle="yes">Physicochemical parameters</italic></bold>
</p><p>Extinction coefficient, theoretical isoelectric point (pI), molecular weight, total number of positive and negative residues, half-life, instability index, aliphatic index and grand average hydropathy (GRAVY), and the physicochemical parameters were computed using Expasy's ProtParam (http://us.expasy.org/tools/ protparam.html) (<xref rid="B28" ref-type="bibr">28</xref>).</p><p>
<bold><italic toggle="yes">Prediction of antigenic B-cell epitopes</italic></bold>
</p><p>Three web-based B-cell epitope prediction algorithms, Bcepred http://www.imtech.res.in/-raghava/bcepred/, Continuous B-cell epitopes prediction methods based on physico-chemical properties on a non-redundant dataset and Discotope Server http://www.cbs.dtu.dk/services/-DiscoTope/ were used in order to predict discontinuous B-cell epitopes from three dimensional protein structures for analyzing amino acid sequence. Briefly, chimeric proteins were first analyzed for continuous B-cell epitopes using Bcepred and all predicted B-cell epitopes (20 mers) having a BcePreds cutoff score &gt;0.8 were selected. Then the Discotope server was used to predict discontinuous B-cell epitopes. Conformational B-cell epitope from primary sequence was predicted with web server CBTOPE (<xref rid="B29" ref-type="bibr">29</xref>). Surface exposed B-cell epitope sequences having cutoff value for BcePreds (&gt;0.8) were selected and analyzed further using VaxiJen (threshold=0.4, ACC output) to check the antigenicity. In addition, location of conformational epitopes on protein surface was defined by Episearch software (<xref rid="B30" ref-type="bibr">30</xref>).</p><p>
<bold><italic toggle="yes">Prediction of T-cell epitopes</italic></bold>
</p><p>In order to identify common epitopes that bind to both MHC class molecules as well as to count the total number of interacting MHC alleles, Propred-1 (MHC Class-I alleles) (<xref rid="B31" ref-type="bibr">31</xref>) and Propred (MHC Class-II alleles) (<xref rid="B32" ref-type="bibr">32</xref>) servers utilizing amino acid position coefficients were used. The half maximal (50%) inhibitory concentration (IC50) and antigenicity of common epitopes being predicted by Propred-1 and Propred were calculated using MHCPred server (<xref rid="B33" ref-type="bibr">33</xref>) and VaxiJen, respectively.</p><p>
<bold><italic toggle="yes">Prediction of RNA secondary structure</italic></bold>
</p><p>Program &#8216;mfold&#8217; http://www.bioinfo.rpi.edu/-applications/mfold was used to analyze the secondary structure of messenger RNA of the chimeric gene. RNA secondary structure was compared before and after gene optimization. Results were confirmed by other online servers such as CentroidFold Web Server (<xref rid="B34" ref-type="bibr">34</xref>).</p><p>
<bold><italic toggle="yes">Protein secondary structure</italic></bold>
</p><p>Prediction of secondary structure of the protein was performed by GOR secondary structure prediction method (<xref rid="B35" ref-type="bibr">35</xref>). In order for sequence analysis and prediction of protein structure and function such as low-complexity regions, regions lacking regular structure, secondary structure, solvent accessibility, trans-membrane helices, coiled-coil regions, disulfide-bonds, sub-cellular localization as well as functional annotations, PredictProtein server (<xref rid="B36" ref-type="bibr">36</xref>) was used .</p><p>
<bold><italic toggle="yes">Tertiary structure prediction</italic></bold>
</p><p>Further analysis of the synthetic protein 3D structural stability was done by Swiss-PdbViewer for energy minimization (<xref rid="B37" ref-type="bibr">37</xref>). The Swiss model is an automated modeling software developing the 3D structure model of unknown structure protein based on the sequence homology with the known structured protein. In order to visualize the modeled 3D structures, Rasmol tool and Accelrys Discovery Studio 2.5 were used. </p><p>
<bold><italic toggle="yes">Tertiary structure validation</italic></bold>
</p><p>In order to recognize errors in the generated models, their 3D structures were uploaded into</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Schematic model displaying the construction of TF, BP26 and Omp 31, bound together by the linkers for expression in prokaryotic cells</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ijbms-17-172-g001.jpg"/></fig><p>ProSA web which is frequently employed in protein structure validation (<xref rid="B38" ref-type="bibr">38</xref>). The structure was validated to see the quality of obtained structural stereochemistry by Ramachandran plot in PROCHECK software (<xref rid="B39" ref-type="bibr">39</xref>). GROMOS96 implemented in SWISS-MODEL software was used to verify the energy minimization of the model structure (<xref rid="B40" ref-type="bibr">40</xref>). The GROMOS96 helps to reduce the bond stretch energy of the modeled protein. It incorporates both bonded and non-bonded forms of energy occupied in the protein molecule.</p><p>
<bold><italic toggle="yes">Protein solubility prediction</italic></bold>
</p><p>Solvent accessibility of different residues was evaluated by DSSP and (VADAR) http://redpoll.- pharmacy.ualberta.ca/vadar/.</p><p>
<bold><italic toggle="yes">Allergenic sites prediction</italic></bold>
</p><p>AlgPred was used to analyze the presence of possible allergenic sites. AlgPred allows predicating allergens based on the similarity of known epitopes with any region of protein. Further analysis of allergenicity was done by homology search in SDAP database (<xref rid="B41" ref-type="bibr">41</xref>).</p></sec><sec sec-type="results"><title>Results</title><p>
<bold><italic toggle="yes">Design and construction of the chimeric gene</italic></bold>
</p><p>Being reported as strong immunogens (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B9" ref-type="bibr">9</xref>), TF protein and two peptides of <italic toggle="yes">B. melitensis</italic>, 27 and18 amino acids from Omp31 and BP26, respectively, were selected for the present study. Sequence comparison by ClustalW showed that these sequences were highly conserved among different strains of <italic toggle="yes">B.</italic>
<italic toggle="yes">melitensis</italic>. The schematic diagram of protein domain structures with linker's sites is shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. Linkers, consisting EAAAK repeats and expecting to form a monomeric hydrophobic &#945;-helix, were designed and used to separate the different domains. It has been reported that salt bridge Glu--Lys+ between the repeated Ala can stabilize helix formation. Four repeated EAAAK sequences were introduced between different domains for more flexibility and efficient separating. Arrangements of fragment junctions and linker sites are shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p><p>The amino acid was back translated based on <italic toggle="yes">Escherichia coli</italic> host and the synthetic chimera was analyzed for their codon bias and GC content. Codon adaptation index on the optimized chimeric gene was 0.98. </p><p>Percentage of codon having a frequency distribution of 91&#8211;100 in the native chimeric gene was 45% which was significantly improved to 70% in the optimized gene sequence. The overall GC content, which is a measurement of transcriptional and translational efficiency, was improved to 52. Polyadenylation signal, instability elements, and all the <italic toggle="yes">cis</italic>-acting sites that may have a negative influence on the expression rate were removed. Furthermore, the necessary restriction enzyme sites (<italic toggle="yes">EcoRI</italic> and <italic toggle="yes">Hind</italic>III) were introduced at the sequence ends for cloning purpose. </p><p>
<bold><italic toggle="yes">Prediction of mRNA structure </italic></bold>
</p><p>In order to determine the potential folding of the chimeric gene, genetic algorithm-based RNA secondary structure prediction was combined with comparative sequence analysis. The 5' terminus of the gene was folded typically as in all bacterial gene structures. Prediction of the minimum free energy for secondary structures formed by RNA molecules was also carried out. All 15 structural elements obtained in this analysis revealed folding of the RNA construct. &#916;G of the best predicted structure was &#8722;217.92 kcal/mol and the first nucleotides at 5&#8242; did not have a long stable hairpin or pseudoknot (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref rid="B42" ref-type="bibr">42</xref>).</p><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Analysis of mRNA stability and start codon in the structure</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ijbms-17-172-g002.jpg"/></fig><fig id="F3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Analysis of chimeric protein secondary structure</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ijbms-17-172-g003.jpg"/></fig><p>
<bold><italic toggle="yes">The physico-chemical parameters</italic></bold>
</p><p>The average molecular weight of synthetic chimeric protein was 61.5 kDa. Isoelectric point (pI) was defined as a pH at which the surface of protein was covered with charge but the net charge of the protein would be zero. The biocomputed half-life was greater than 10 hr. Acidity of the protein was indicated by the pI value, pI: 4.96. On the basis of instability index, Expasy's ProtParam classified the optimized chimeric protein as stable (Instability index: 44.64). Aliphatic index of synthetic chimeric protein was 80.11. Extinction coefficient of optimized chimeric protein at 280 nm was 24870 M<sup>&#8722;1</sup> cm<sup>&#8722;1</sup>.</p><p>
<bold><italic toggle="yes">Secondary structure prediction</italic></bold>
</p><p>Results showed total residues of 552 which were made up of 39 strands, 324 helices and 189 Random coil. <xref ref-type="fig" rid="F3">Figure 3</xref> shows secondary structure of fusion protein construction. The results demonstrated that there is a helix located between positions 485-495 and 520-525 that corresponded to the linker fragment (<xref ref-type="fig" rid="F3">Figure 3</xref>). For locating the signal peptide cleavage sites based on neural networks (NN) trained on Gram negative bacteria, SignalP prediction was used. Accordingly, signal peptide cleavage sites were not predicted. </p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Epitope predicted chimeric protein by physico and chemical properties based on Bcepred</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Prediction parameters</th><th align="center" valign="middle" rowspan="1" colspan="1">Epitope segments</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hydrophilic</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">ETARGRA, LNDSSRSI, AERNEKSATQPE,MSEDEKEAEKV, SDEEVDEQV,ETKKGKAENEDRVT, EGGADNDAQ,KAGDEKV,LDDETAKK,GRTFEDEETTEEAAREE,YPGQEKE,TDKKVSKEELTAEDEDAASEAKPAK, PKKKAEEGKSEEAEAAA, AGIEDRDLQTG, PDEAAAKN,SSFDKEDNEQVSGS</italic>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Flexibility</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">MTRSEG, ERLETAR, EILNDSSRSILAERNEKS, VIMSEDEKEA, KRIASSTRTFETKKGKA, IGLKAGD, GQITRQKVK, FEDEETT, RRYPGQE, NVTDKKVSK, KAAPKKKAEEGKSEE, HPFSSFDKEDNEQVS</italic>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Accessibility</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">TRSEGLN, LNEGLKREIKVV, EAKLAERLETARGRARINGFRPGKVPTAHLRKMYGKS, LNDSSRSILAERNEKSATQPE, IMSEDEKEAEKVLDGK, EVKDFSK, SDEEVDEQVKRIASSTRTFETKKGKAENEDRVTI, LKAGDEKV, KVKEVAKPNE, LDDETAKKLGIESLERLRQVVREQIESQYGQITRQKVKRQIL, DGDYQFETPQKLVD, DLQQAGRTFEDEETTEEAAREEYRKLAERRVRLG, VEVTEEELQRAVYDQVRRYPGQEKEIYDFLRRTPDAV, EEKVVDH, INVTDKKVSKEELTAEDEDAASEAKPAKKAAAKKKAAPKKKAEEGKSEEAEA, KEAAAKKKAGIEDRDLQTG, PDEAAAKN, KFKHPFSSFDKEDNEQVS</italic>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Exposed surface</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">NEGLKRE, RKMYGKS, LAERNEKSA, MSEDEKEAEKV, VDEQVKRI, RTFETKKGKAENEDR, KVKEVAKPN, DDETAKKL, ITRQKVKRQIL, QFETPQK, AREEYRKLAERR, TEEELQR, YDQVRRYPGQEKEIYD, TDKKVSKEEL, EAKPAKKAAAKKKAAPKKKAEEGKSEE, KEAAAKKKAGIE, FDKEDNEQV</italic>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Polarity</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">LNEGLKREIKVV, EAKLAERLETARGRARIN, PTAHLRKMYGKS, RSILAERNEKSAT, IMSEDEKEAEKVLDGK, EVKDFSKIAVTRE, VDISDEEVDEQVKRIA, TRTFETKKGKAENEDRVTID, LKAGDEKV, FDIKVKEVAKPNELVLDDETAKKLGIESLERLRQVVREQIESQ, ITRQKVKRQIL, GRTFEDEETTEEAAREEYRKLAERRVRLGL, VEVTEEELQRAV, RRYPGQEKEIYDF, RAPIFEEKVVDHL, TDKKVSKEELTAEDEDAASEAKPAKKAAAKKKAAPKKKAEEGKSEEAEA, KEAAAKKKAGIEDRDLQT, GGKFKHPFSSFDKEDNEQV</italic>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Antigen propensity</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">REIKVVVP, FVFSLNYEVLP, VTREVVD, QLVLGSGQ, KVITVTFP, ERLRQVVREQI, RVRLGLVLSEIG, IFEEKVVDHLL, NIQPIYVYPDE</italic>
</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Discontinuous B-cell epitopes prediction based on Discotope server</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Residues</th><th align="left" valign="middle" rowspan="1" colspan="1">Number of residues</th><th align="left" valign="middle" rowspan="1" colspan="1">Score</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">T164, R165, T166, F167, E168, T169, K170, K171, G172, K173, A174, E175, N176, D178, R179, V180, T181, I182, D183, Y184, L185, G186, K187, L188, D189, G190, E191, P192, F193, E194, G195, G196, A197, D198, N199, D200, A201, Q202, F210, I211, P212, G213, F214, Q217, L218, I219, G220, L221, K222, A223, G224, D225, E226, K227, V228, I229, T230, V231, T232, F233, P234, A235, E236, Y237, G238, A239, A240, H241, L242, A243, G244, K245, E246, A247, T248, F249, D250, I251, K252, V253, K254, E255, V256, A257, K258, N260, E261, L262, V263, L264, D265, D266, E267, T268, A269, K270, K271, L272, G273, I274, E275, S276, _:L277, E278, R279, L280</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">106</td><td align="left" valign="middle" rowspan="1" colspan="1">0.762</td></tr></tbody></table></table-wrap><p>
<bold><italic toggle="yes">Tertiary structure prediction of the fusion protein</italic></bold>
</p><p>Tertiary structure of the fusion protein was predicted by uploading several models to I-TASSER server (<xref rid="B43" ref-type="bibr">43</xref>). Tertiary predication result of the fusion protein construction showed a protein with three domains linked together with linkers. In order to check 3D models of protein structures for potential errors, ProSA was employed. The z-score of the input structure was within the range of scores typically found for native proteins of the similar size (<xref ref-type="fig" rid="F4">Figure 4</xref>). The confidence score (C-score) for estimating the quality of predicted models by I-TASSER was 2.45. C-score is typically in the range of [&#8722;5 to 2], where a C-score of higher value signifies the model with a high confidence. In addition, the expected TM-score for this model was 0.54&#177;0.15. The expected RMSD was 10.9&#177;4.6.</p><p>
<bold><italic toggle="yes">Evaluation of model stability</italic></bold>
</p><p>In order to calculate the profile of energy minimization, Spdbv (Swiss-PdbViewer) was used. The amount -14047.257 Kcal/mol indicated that the synthetic chimeric protein had acceptable stability compared to that of original structure of each domain. Additionally, the structural stability of the protein was confirmed by data generation using Ramachandran plot (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p><p>
<bold><italic toggle="yes">Solvent accessibility prediction</italic></bold>
</p><p>Major hydrophobic and polarity properties of residual patterns were used to characterize the solvent accessibility distributions. These patterns illustrated that the mean residue accessible surface area (ASA) had given a high solvent accessibility value, approximately fifty percent (Data not shown) (<xref rid="B44" ref-type="bibr">44</xref>).</p><p>
<bold><italic toggle="yes">Antigenic B-cell and T-cell epitopes</italic></bold>
</p><p>If an antigen is hydrophilic and produces both the B-cell and T-cell mediated immunity, it will be a satisfactory vaccine candidate. Therefore, BCpreds and AAPpreds were used to predict B-cell epitopes of full length protein. The Best epitopes were selected according to the criteria based on cutoff values for BCpreds, AAPpreds and VaxiJen which were &gt;0.8, &gt;0.8 and &gt;0.4, respectively (<xref ref-type="table" rid="T1">Table 1</xref>). Furthermore, CBTOPE and Discotope servers were used to predict the conformational epitopes of B-cells (<xref ref-type="table" rid="T2">Table 2</xref>). Each selected B-cell epitope was analyzed for identification of T-cell Propred-I (18 MHC Class-I alleles) and Propred (20 MHC Class-II alleles), by means of MHC Pred to identify the common T-cell epitopes which could interact with both MHC classes I and II with the highest number (<xref ref-type="table" rid="T3">Tables 3</xref> and <xref ref-type="table" rid="T4">4</xref>).</p><fig id="F4" position="float" orientation="portrait"><label>Figure 4</label><caption><p>
<italic toggle="yes">Ab- initio</italic> and comparative modeling was employed to predict the 3D structure of the chimeric protein, TF-BP26-Omp31. The result was viewed by Accelrys Discovery Studio Visualizer 2.0 software. The linkers are displayed in yellow color</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ijbms-17-172-g004.jpg"/></fig><fig id="F5" position="float" orientation="portrait"><label>Figure 5</label><caption><p>Ramachandran plot for the chimeric protein, TF-BP26-Omp31.Number of residues in favored region (~98.0% expected): 501(91.1%) Number of residues in the allowed region (~2.0% expected): 33 (6.0%) Number of residues in outlier region: 16 (2.9%)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ijbms-17-172-g005.jpg"/></fig><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3</label><caption><p>The result of prediction for MHCI epitopes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Rank</th><th align="center" rowspan="1" colspan="1">Sequence</th><th align="center" rowspan="1" colspan="1">Score</th><th align="center" rowspan="1" colspan="1">Position</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">VLDGKADFV</italic>
</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">112-120</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">RLRQVVREQ</italic>
</td><td align="center" rowspan="1" colspan="1">0.64</td><td align="center" rowspan="1" colspan="1">279-287</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">SLERLRQVV</italic>
</td><td align="center" rowspan="1" colspan="1">0.55</td><td align="center" rowspan="1" colspan="1">276-284</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">KLAERRVRL</italic>
</td><td align="center" rowspan="1" colspan="1">0.49</td><td align="center" rowspan="1" colspan="1">359-367</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">GINIQPIYV</italic>
</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">509-517</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">GLNMQVTET</italic>
</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">6-14</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">GLKREIKVV</italic>
</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">18-26</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">FLRRTPDAV</italic>
</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">408-416</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">VLGSGQFIP</italic>
</td><td align="center" rowspan="1" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">204-212</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">GLKAGDEKV</italic>
</td><td align="center" rowspan="1" colspan="1">0.37</td><td align="center" rowspan="1" colspan="1">220-228</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">RLGLVLSEI</italic>
</td><td align="center" rowspan="1" colspan="1">0.36</td><td align="center" rowspan="1" colspan="1">366-374</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">ILNDSSRSI</italic>
</td><td align="center" rowspan="1" colspan="1">0.36</td><td align="center" rowspan="1" colspan="1">78-86</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">TLNEGLKRE</italic>
</td><td align="center" rowspan="1" colspan="1">0.35</td><td align="center" rowspan="1" colspan="1">14-22</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">VTIDYLGKL</italic>
</td><td align="center" rowspan="1" colspan="1">0.33</td><td align="center" rowspan="1" colspan="1">180-188</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">GKADFVFSL</italic>
</td><td align="center" rowspan="1" colspan="1">0.26</td><td align="center" rowspan="1" colspan="1">115-123</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">KLAERLETA</italic>
</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">35-43</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">DLQTGGINI</italic>
</td><td align="center" rowspan="1" colspan="1">0.23</td><td align="center" rowspan="1" colspan="1">504-512</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">VLDDETAKK</italic>
</td><td align="center" rowspan="1" colspan="1">0.20</td><td align="center" rowspan="1" colspan="1">263-271</td></tr></tbody></table></table-wrap><p>
<bold><italic toggle="yes">Other properties of the construct</italic></bold>
</p><p>AlgPred tool and SDAP allergen library were used to predict the allergenicity of the sequence. Based on different approaches for allergenicity prediction in AlgPred tool, this protein was not detected as potential allergen. Finally, search for allergens showed no significant similarities between any of the regions and SDAP allergen library.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>New strategies are required to protect Brucellosis while avoiding the disadvantages of the currently used live vaccines. Subunit vaccines are an attractive approach for development of effective recombinant vaccines. Although considerable work has been carried out on numerous cell surface and intracellular components, only a few antigens have shown significant protective activity (<xref rid="B6" ref-type="bibr">6</xref>, -). Trigger Factor (TF) protein is an ATP-independent chaperone that displays chaperone and peptidyl-prolyl-cis-trans-isomerase activities <italic toggle="yes">in vitro</italic> (<xref rid="B48" ref-type="bibr">48</xref>). The positioning of TF at the peptide exit channel, together with its ability to interact with nascent chains as short as 57 residues, renders TF a prime candidate for being the first chaperone that binds to the nascent polypeptide chains (<xref rid="B49" ref-type="bibr">49</xref>). TF has also been reported to act as a protective antigen against <italic toggle="yes">B. melitensis</italic> infection (<xref rid="B6" ref-type="bibr">6</xref>). It has previously been shown that <italic toggle="yes">Brucella </italic>periplasmic protein, BP26, could be used to distinguish vaccinated livestock from naturally infected animals (<xref rid="B50" ref-type="bibr">50</xref>). BP26 is highly conserved among <italic toggle="yes">B. abortus</italic>, <italic toggle="yes">B. suis</italic>, <italic toggle="yes">B. ovis</italic>, and <italic toggle="yes">B. melitensis </italic>(<xref rid="B51" ref-type="bibr">51</xref>). Thus, research into this protein has mostly focused on its diagnostic properties in the infected livestock and humans (<xref rid="B52" ref-type="bibr">52</xref>). It has been reported that BP26 has vaccine potential when combined with TF. (<xref rid="B6" ref-type="bibr">6</xref>). Epitope mapping has been shown that two epitopes of BP26 were very important to its immunogenicity and reaction with infected sheep sera (<xref rid="B9" ref-type="bibr">9</xref>). It is also said that the recombinant Omp31 either being associated or notwith <italic toggle="yes">B. ovis </italic>R-LPS, could give an acceptable protection against <italic toggle="yes">B. ovis </italic>infection (<xref rid="B53" ref-type="bibr">53</xref>). Immunization with a synthetic peptide comprising residues 48&#8211;74 of Omp31 (Omp31<sup>48&#8211;74</sup>) has induced a T-helper (Th) 1 response that conferred protection against <italic toggle="yes">B. melitensis</italic>, indicating that this sequence contains a Th1 protective epitope (<xref rid="B7" ref-type="bibr">7</xref>). These features attracted our attention to this peptide loop as one potential component for a subcellular vaccine. </p><p>Herein, we designed new construct of <italic toggle="yes">B. melitensis</italic> antigens including TF, Omp31<sup>48&#8211;74</sup> and BP26<sup>93-111</sup> that contained protective and immunogenic antigens. The usage of linkers is very important in the design of functional chimeric proteins since linkers can play a critical role in displaying specific epitopes in the overall structure of the fusion protein (<xref rid="B54" ref-type="bibr">54</xref>). Use of linkers consisting EAAAK repeats and expected to form a monomeric hydrophobic &#945;-helix has been previously described (<xref rid="B24" ref-type="bibr">24</xref>). In order to improve the transcription efficiency and transcript stability, codon optimization was performed. This was achieved by improving codon adaptation index and codon frequency distribution, the overall GC content of the gene and removing negative elements that may incorporate unfavorable secondary structures on mRNA. A codon adaptation index of 0.98 was obtained by the optimized gene sequence indicating that the optimized gene sequence can be expressed well. A suitable biased gene would be a codon adaptation index (CAI) of 1.0, although no natural bacterial gene has this theoretical value (<xref rid="B24" ref-type="bibr">24</xref>). The average energy minimization was near -14047.257 that were shown in graphical depiction of the predicted minimum free energy for the synthetic gene. Regarding protein structure prediction, the chimeric protein formed three domains that were separated by two main &#945;-helix moieties which can help the protein to form a final structure. These &#945;-helix structures are related to the designation of special amino acid sequences, residues 485-495 and 520-525 inserted between domains. These parts can support the stable structure of a protein which contained three domains. Mfold was one of the softwares used for prediction of RNA secondary structure. Mfold employs a theoretically tractable DP algorithm which can find the minimum &#916;G structure within its thermodynamic model and high ability to predict true positive base pairs. Data from mRNA structure prediction showed that the mRNA was stable enough for efficient translation in the host. The physico-chemical parameters of chimeric protein were analyzed. The pI value of protein (pI: 4.96) showed acidic nature of the protein. Extinction coefficient of synthetic chimeric protein at 280 nm was high, indicating the presence of high concentrations of Glu, Lys and Asp. On the basis of instability index, Expasy's ProtParam classifies the synthetic chimeric protein as stable instability index of 44.64. High aliphatic index of the synthetic chimeric protein indicates that the protein may be stable in a wide range of temperature.</p><table-wrap id="T4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Prediction of MHC II epitopes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Rank</th><th align="center" rowspan="1" colspan="1">Start position</th><th align="center" rowspan="1" colspan="1">Residue listing</th><th align="center" rowspan="1" colspan="1">Score </th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">FMAEIVNEI</italic>
</td><td align="center" rowspan="1" colspan="1">326.845</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">359</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">KLAERRVRL</italic>
</td><td align="center" rowspan="1" colspan="1">306.550</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">KMYGKSFMA</italic>
</td><td align="center" rowspan="1" colspan="1">233.076</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">312</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">YQFETPQKL</italic>
</td><td align="center" rowspan="1" colspan="1">151.142</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">112</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">VLDGKADFV</italic>
</td><td align="center" rowspan="1" colspan="1">127.461</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">119</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">FVFSLNYEV</italic>
</td><td align="center" rowspan="1" colspan="1">103.580</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">KLAERLETA</italic>
</td><td align="center" rowspan="1" colspan="1">80.345</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">509</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">GINIQPIYV</italic>
</td><td align="center" rowspan="1" colspan="1">52.599</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">203</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">LVLGSGQFI</italic>
</td><td align="center" rowspan="1" colspan="1">31.581</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">210</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">FIPGFEEQL</italic>
</td><td align="center" rowspan="1" colspan="1">25.159</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">101</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">IMSEDEKEA</italic>
</td><td align="center" rowspan="1" colspan="1">25.008</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">366</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">RLGLVLSEI</italic>
</td><td align="center" rowspan="1" colspan="1">23.995</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">245</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">KEATFDIKV</italic>
</td><td align="center" rowspan="1" colspan="1">17.987</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">GLNMQVTET</italic>
</td><td align="center" rowspan="1" colspan="1">17.140</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">370</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">VLSEIGEKA</italic>
</td><td align="center" rowspan="1" colspan="1">16.967</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">ILNDSSRSI</italic>
</td><td align="center" rowspan="1" colspan="1">14.543</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">408</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">FLRRTPDAV</italic>
</td><td align="center" rowspan="1" colspan="1">11.915</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">122</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">SLNYEVLPA</italic>
</td><td align="center" rowspan="1" colspan="1">11.426</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">435</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">NINVTDKKV</italic>
</td><td align="center" rowspan="1" colspan="1">9.563</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">227</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">KVITVTFPA</italic>
</td><td align="center" rowspan="1" colspan="1">8.824</td></tr></tbody></table></table-wrap><p>Both <italic toggle="yes">ab-initio</italic> methods and comparative were used for predicting three-dimensional structure of the chimeric protein. Synthetic chimeric protein has templates in the PDB library on the basis of which the 3D model structure of the protein was generated by Swiss model software.</p><p>Our results emphasize that <italic toggle="yes">ab-initio</italic> I-TASSER software can predict the folds as well as good resolution model for synthetic chimeric protein. </p><p>Assessments of reliability and accuracy of experimental and theoretical models of protein structures are necessary. Therefore, the evaluation of the predicted models using both RMSD and TM-score were done. The best RMSD value was the result of our model on template consisting of 552 amino acids; 100% of total protein residues. Expected TM-score of 0.54&#177;0.15 validates the accuracy of the model. A model of correct topology was indicated by a TM-score of &gt; 0.5, its confidence being achieved by other scores including z-score and C-score. The z-score indicates overall model quality and measures the deviation of the total energy of the structure with respect to an energy distribution derived from random conformations. Z-scores, outside of a characteristic range for native proteins, indicat erroneous structures. The ProSA-web results showed that synthetic chimeric protein has features which are the characteristics of native structures. Our chimeric structure showed desirable protein stability based on Ramachandran plot predictions. A negligible 2.9% of the residues were found in Ramachandran plot analysis to be in outliner region that could probably be due to the presence of chimeric junctions. </p><p>An effective vaccine candidate should be able to induce strong B-cell and T-cell responses. For this reason, T-cell and B-cell epitopes mapping are an important method for designing an optimal vaccine. In order to predict linear B-cell epitopes from each protein, BCpreds was employed using a novel method of subsequence kernel. The methods employed for prediction of linear epitopes led to almost identical results with some minor differences. Prediction of conformational epitopes in antibody-antigen interaction is a crucial step for satisfactory design of novel drugs and vaccines (<xref rid="B30" ref-type="bibr">30</xref>). Conformational epitopes were predicted with structure-based method and sequence information methods. Our results showed that the structural epitopes derived from CBTOPE and DiscoTope were almost similar.</p><p>In this study, the potential T-cell epitopes derived from antigenic B-cell epitopes of chimeric proteins were identified. The selected T-cell epitopes were antigenic with potential to interact with human HLA alleles. Thus, this synthetic chimeric protein had potential to induce both the B-cell and T-cell mediated immune responses. The solubility chance of protein (49.5%) showed that it can be purified under normal conditions when expressed in <italic toggle="yes">E. coli</italic>. Finally, no considerable similarity between any region and SDAP allergen library was observed.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Our data indicates that epitopes of the synthetic chimeric protein could induce both B-cell and T-cell mediated immune responses which are important for a protective vaccine against Brucellosis. Our data may also suggest this synthetic chimeric protein as a vaccine candidate subunit. Further study is required to establish this notion which is the theme of our future research. </p></sec></body><back><ack><title>Acknowledgment</title><p>The current research was supported by Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</p></ack><sec><title>Conflict of interest</title><p>The authors declare no competing interest.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siadat</surname><given-names>SD</given-names></name><name name-style="western"><surname>Sharifat</surname><given-names>Salmani A</given-names></name><name name-style="western"><surname>Aghasadeghi</surname><given-names>MR</given-names></name></person-group><article-title>Brucellosis Vaccines: An Overview, Zoonosis</article-title><year>2012</year></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Pasquevich</surname><given-names>K</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>L</given-names></name><name name-style="western"><surname>Wallach</surname><given-names>JC</given-names></name><name name-style="western"><surname>Fossati</surname><given-names>CA</given-names></name><name name-style="western"><surname>Baldi</surname><given-names>PC</given-names></name></person-group><article-title>Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae</article-title><source> Clin Diagn Lab Immunol</source><year>2004</year><volume>11</volume><fpage>111</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">14715555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CDLI.11.1.111-114.2004</pub-id><pub-id pub-id-type="pmcid">PMC321362</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>D</given-names></name><name name-style="western"><surname>Lang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection</article-title><source> FEMS Immunol Med Microbiol</source><year>2011</year><volume>61</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">21166726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1574-695X.2010.00758.x</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Luo</surname><given-names>D</given-names></name><name name-style="western"><surname>Xing</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name><name name-style="western"><surname>Duan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella</article-title><source> Vaccine</source><year>2009</year><volume>27</volume><fpage>5214</fpage><lpage>5219</lpage><pub-id pub-id-type="pmid">19596411</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2009.06.075</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sciutto</surname><given-names>E</given-names></name><name name-style="western"><surname>Toledo</surname><given-names>A</given-names></name><name name-style="western"><surname>Cruz</surname><given-names>C</given-names></name><name name-style="western"><surname>Rosas</surname><given-names>G</given-names></name><name name-style="western"><surname>Meneses</surname><given-names>G</given-names></name><name name-style="western"><surname>Laplagne</surname><given-names>D</given-names></name><etal/></person-group><article-title>Brucella spp lumazine synthase: a novel antigen delivery system. </article-title><source>Vaccine</source><year>2005</year><volume>23</volume><fpage>2784</fpage><lpage>2790</lpage><pub-id pub-id-type="pmid">15780726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2004.11.043</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>M</given-names></name><name name-style="western"><surname>Walters</surname><given-names>N</given-names></name><name name-style="western"><surname>Bargatze</surname><given-names>RF</given-names></name><name name-style="western"><surname>Pascual</surname><given-names>DW</given-names></name></person-group><article-title>Selection of protective epitopes for Brucella melitensis by DNA vaccination</article-title><source> Infect Immun</source><year>2005</year><volume>73</volume><fpage>7297</fpage><lpage>7303</lpage><pub-id pub-id-type="pmid">16239526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.73.11.7297-7303.2005</pub-id><pub-id pub-id-type="pmcid">PMC1273852</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Pasquevich</surname><given-names>KA</given-names></name><name name-style="western"><surname>Velikovsky</surname><given-names>CA</given-names></name><name name-style="western"><surname>de</surname><given-names>la Barrera S</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>R</given-names></name><etal/></person-group><article-title>Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection</article-title><source> Infect Immun</source><year>2005</year><volume>73</volume><fpage>8079</fpage><lpage>8088</lpage><pub-id pub-id-type="pmid">16299302</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.73.12.8079-8088.2005</pub-id><pub-id pub-id-type="pmcid">PMC1307072</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Debbarh</surname><given-names>HS</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Dubray</surname><given-names>G</given-names></name></person-group><article-title>Production and characterisation of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody responses of infected sheep from Rev</article-title><source>J Med Microbiol</source><year>1996</year><volume>45</volume><fpage>206</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">8810948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/00222615-45-3-206</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>J</given-names></name><etal/></person-group><article-title>Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies</article-title><source> PloS One</source><year>2012</year><volume>7</volume><fpage>e34246</fpage><pub-id pub-id-type="pmid">22457830</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0034246</pub-id><pub-id pub-id-type="pmcid">PMC3311636</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghasemi</surname><given-names>A</given-names></name><name name-style="western"><surname>Salari</surname><given-names>MH</given-names></name><name name-style="western"><surname>Pourmand</surname><given-names>MR</given-names></name><name name-style="western"><surname>Zarnani</surname><given-names>AH</given-names></name><name name-style="western"><surname>Ahmadi</surname><given-names>H</given-names></name><name name-style="western"><surname>Shirazi</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Immune Reactivity of Brucella melitensis &#8211;Vaccinated rabbit serum with Recombinant Omp31 and DnaK proteins</article-title><source> Iran J Microbiol</source><year>2013</year><volume>5</volume><fpage>19</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">23467315</pub-id><pub-id pub-id-type="pmcid">PMC3577567</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Vizcaino</surname><given-names>N</given-names></name><name name-style="western"><surname>Paquet</surname><given-names>JY</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>RA</given-names></name><name name-style="western"><surname>Elzer</surname><given-names>PH</given-names></name></person-group><article-title>Major outer membrane proteins of Brucella spp : past, present and future. </article-title><source>Vet Microbiol</source><year>2002</year><volume>90</volume><fpage>229</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">12414146</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-1135(02)00211-0</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Pasquevich</surname><given-names>KA</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Laplagne</surname><given-names>DA</given-names></name><name name-style="western"><surname>Velikovsky</surname><given-names>CA</given-names></name><name name-style="western"><surname>de</surname><given-names>la Barrera S</given-names></name><etal/></person-group><article-title>A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B ovis than Rev.1 vaccination. </article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>4437</fpage><lpage>4446</lpage><pub-id pub-id-type="pmid">17442465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2007.03.028</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Commander</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Wren</surname><given-names>BW</given-names></name><name name-style="western"><surname>MacMillan</surname><given-names>AP</given-names></name></person-group><article-title>The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes</article-title><source> Vaccine</source><year>2007</year><volume>25</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17049676</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2006.07.046</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>D</given-names></name><name name-style="western"><surname>Ni</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Han</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice</article-title><source> Infect Immun</source><year>2006</year><volume>74</volume><fpage>2734</fpage><lpage>2741</lpage><pub-id pub-id-type="pmid">16622210</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.74.5.2734-2741.2006</pub-id><pub-id pub-id-type="pmcid">PMC1459688</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Araya</surname><given-names>LN</given-names></name><name name-style="western"><surname>Winter</surname><given-names>AJ</given-names></name></person-group><article-title>Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum</article-title><source> Infect Immun</source><year>1990</year><volume>58</volume><fpage>254</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">2104599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.58.1.254-256.1990</pub-id><pub-id pub-id-type="pmcid">PMC258438</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velikovsky</surname><given-names>CA</given-names></name><name name-style="western"><surname>Goldbaum</surname><given-names>FA</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Estein</surname><given-names>S</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>RA</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>L</given-names></name><etal/></person-group><article-title>Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used</article-title><source> Infect Immun</source><year>2003</year><volume>71</volume><fpage>5750</fpage><lpage>5755</lpage><pub-id pub-id-type="pmid">14500496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.71.10.5750-5755.2003</pub-id><pub-id pub-id-type="pmcid">PMC201088</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Mariri</surname><given-names>A</given-names></name><name name-style="western"><surname>Tibor</surname><given-names>A</given-names></name><name name-style="western"><surname>Mertens</surname><given-names>P</given-names></name><name name-style="western"><surname>De</surname><given-names>Bolle X</given-names></name><name name-style="western"><surname>Michel</surname><given-names>P</given-names></name><name name-style="western"><surname>Godefroid</surname><given-names>J</given-names></name><etal/></person-group><article-title>Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant</article-title><source> Infect Immun</source><year>2001</year><volume>69</volume><fpage>4816</fpage><lpage>4822</lpage><pub-id pub-id-type="pmid">11447155</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.69.8.4816-4822.2001</pub-id><pub-id pub-id-type="pmcid">PMC98569</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cespedes</surname><given-names>S</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>E</given-names></name><name name-style="western"><surname>Folch</surname><given-names>H</given-names></name><name name-style="western"><surname>Onate</surname><given-names>A</given-names></name></person-group><article-title>Identification and partial characterisation of a new protective antigen of Brucella abortus</article-title><source> J Med Microbiol</source><year>2000</year><volume>49</volume><fpage>165</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">10670567</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/0022-1317-49-2-165</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabatabai</surname><given-names>LB</given-names></name><name name-style="western"><surname>Pugh</surname><given-names>GW Jr</given-names></name></person-group><article-title>Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine</article-title><source> Vaccine</source><year>1994</year><volume>12</volume><fpage>919</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">7526568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0264-410x(94)90035-3</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>SC</given-names></name><name name-style="western"><surname>Splitter</surname><given-names>GA</given-names></name></person-group><article-title>Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection</article-title><source> Vaccine</source><year>1996</year><volume>14</volume><fpage>959</fpage><lpage>962</lpage><pub-id pub-id-type="pmid">8873388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0264-410x(96)00018-7</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maione</surname><given-names>D</given-names></name><name name-style="western"><surname>Margarit</surname><given-names>I</given-names></name><name name-style="western"><surname>Rinaudo</surname><given-names>CD</given-names></name><name name-style="western"><surname>Masignani</surname><given-names>V</given-names></name><name name-style="western"><surname>Mora</surname><given-names>M</given-names></name><name name-style="western"><surname>Scarselli</surname><given-names>M</given-names></name><etal/></person-group><article-title>Identification of a universal Group B streptococcus vaccine by multiple genome screen</article-title><source> Science</source><year>2005</year><volume>309</volume><fpage>148</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">15994562</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1109869</pub-id><pub-id pub-id-type="pmcid">PMC1351092</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nazarian</surname><given-names>S</given-names></name><name name-style="western"><surname>Mousavi</surname><given-names>Gargari SL</given-names></name><name name-style="western"><surname>Rasooli</surname><given-names>I</given-names></name><name name-style="western"><surname>Amani</surname><given-names>J</given-names></name><name name-style="western"><surname>Bagheri</surname><given-names>S</given-names></name><name name-style="western"><surname>Alerasool</surname><given-names>M</given-names></name></person-group><article-title>An in silico chimeric multi subunit vaccine targeting virulence factors of enterotoxigenic Escherichia coli (ETEC) with its bacterial inbuilt adjuvant</article-title><source> J Microbiol Methods</source><year>2012</year><volume>90</volume><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">22525194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mimet.2012.04.001</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puigbo</surname><given-names>P</given-names></name><name name-style="western"><surname>Guzman</surname><given-names>E</given-names></name><name name-style="western"><surname>Romeu</surname><given-names>A</given-names></name><name name-style="western"><surname>Garcia-Vallve</surname><given-names>S</given-names></name></person-group><article-title>OPTIMIZER: a web server for optimizing the codon usage of DNA sequences</article-title><source> Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>W126</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">17439967</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkm219</pub-id><pub-id pub-id-type="pmcid">PMC1933141</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amani</surname><given-names>J</given-names></name><name name-style="western"><surname>Mousavi</surname><given-names>SL</given-names></name><name name-style="western"><surname>Rafati</surname><given-names>S</given-names></name><name name-style="western"><surname>Salmanian</surname><given-names>AH</given-names></name></person-group><article-title>In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications</article-title><source> Theor Biol Med Model</source><year>2009</year><volume>6</volume><lpage>28</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1742-4682-6-28</pub-id><pub-id pub-id-type="pmcid">PMC3224939</pub-id><pub-id pub-id-type="pmid">19995413</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keramati</surname><given-names>M</given-names></name><name name-style="western"><surname>Roohvand</surname><given-names>F</given-names></name><name name-style="western"><surname>Aslani</surname><given-names>MM</given-names></name><name name-style="western"><surname>Khatami</surname><given-names>S</given-names></name><name name-style="western"><surname>Aghasadeghi</surname><given-names>MR</given-names></name><name name-style="western"><surname>Sadat</surname><given-names>M</given-names></name><etal/></person-group><article-title>Screening, cloning and expression of active streptokinase from an Iranian isolate of S equisimilis Group C in E. coli </article-title><source>Iran J Basic Med Sci</source><year>2013</year><volume>16</volume><fpage>620</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">24250939</pub-id><pub-id pub-id-type="pmcid">PMC3821881</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doytchinova</surname><given-names>IA</given-names></name><name name-style="western"><surname>Flower</surname><given-names>DR</given-names></name></person-group><article-title>VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines</article-title><source> BMC Bioinformatics</source><year>2007</year><volume>8</volume><lpage>4</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2105-8-4</pub-id><pub-id pub-id-type="pmcid">PMC1780059</pub-id><pub-id pub-id-type="pmid">17207271</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iman</surname><given-names>M</given-names></name><name name-style="western"><surname>Saadabadi</surname><given-names>A</given-names></name><name name-style="western"><surname>Davood</surname><given-names>A</given-names></name></person-group><article-title>Docking studies of phthalimide pharmacophore as a sodium channel blocker</article-title><source> Iran J Basic Med Sci</source><year>2013</year><volume>16</volume><fpage>1016</fpage><lpage>1021</lpage><pub-id pub-id-type="pmid">24171082</pub-id><pub-id pub-id-type="pmcid">PMC3804840</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahbar</surname><given-names>MR</given-names></name><name name-style="western"><surname>Rasooli</surname><given-names>I</given-names></name><name name-style="western"><surname>Gargari</surname><given-names>SL</given-names></name><name name-style="western"><surname>Sandstrom</surname><given-names>G</given-names></name><name name-style="western"><surname>Amani</surname><given-names>J</given-names></name><name name-style="western"><surname>Fattahian</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A potential in silico antibody-antigen based diagnostic test for precise identification of Acinetobacter baumannii</article-title><source> J Theor Biol</source><year>2011</year><volume>294</volume><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">22079096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jtbi.2011.10.026</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ansari</surname><given-names>HR</given-names></name><name name-style="western"><surname>Raghava</surname><given-names>GP</given-names></name></person-group><article-title>Identification of conformational B-cell Epitopes in an antigen from its primary sequence</article-title><source> Immunome Res</source><year>2010</year><volume>6</volume><fpage>6</fpage><pub-id pub-id-type="pmid">20961417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1745-7580-6-6</pub-id><pub-id pub-id-type="pmcid">PMC2974664</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Negi</surname><given-names>SS</given-names></name><name name-style="western"><surname>Braun</surname><given-names>W</given-names></name></person-group><article-title>Automated detection of conformational epitopes using phage display Peptide sequences</article-title><source> Bioinformatics Biol Insights</source><year>2009</year><volume>3</volume><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.4137/bbi.s2745</pub-id><pub-id pub-id-type="pmcid">PMC2808184</pub-id><pub-id pub-id-type="pmid">20140073</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>H</given-names></name><name name-style="western"><surname>Raghava</surname><given-names>GP</given-names></name></person-group><article-title>ProPred1: prediction of promiscuous MHC Class-I binding sites</article-title><source> Bioinformatics</source><year>2003</year><volume>19</volume><fpage>1009</fpage><lpage>1014</lpage><pub-id pub-id-type="pmid">12761064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/btg108</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>H</given-names></name><name name-style="western"><surname>Raghava</surname><given-names>GP</given-names></name></person-group><article-title>ProPred: prediction of HLA-DR binding sites</article-title><source> Bioinformatics</source><year>2001</year><volume>17</volume><fpage>1236</fpage><lpage>1237</lpage><pub-id pub-id-type="pmid">11751237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/17.12.1236</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>P</given-names></name><name name-style="western"><surname>Doytchinova</surname><given-names>IA</given-names></name><name name-style="western"><surname>Zygouri</surname><given-names>C</given-names></name><name name-style="western"><surname>Flower</surname><given-names>DR</given-names></name></person-group><article-title>MHCPred: A server for quantitative prediction of peptide-MHC binding</article-title><source> Nucleic Acids Res</source><year>2003</year><volume>31</volume><fpage>3621</fpage><lpage>3624</lpage><pub-id pub-id-type="pmid">12824380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkg510</pub-id><pub-id pub-id-type="pmcid">PMC168917</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamada</surname><given-names>M</given-names></name><name name-style="western"><surname>Kiryu</surname><given-names>H</given-names></name><name name-style="western"><surname>Sato</surname><given-names>K</given-names></name><name name-style="western"><surname>Mituyama</surname><given-names>T</given-names></name><name name-style="western"><surname>Asai</surname><given-names>K</given-names></name></person-group><article-title>Prediction of RNA secondary structure using generalized centroid estimators</article-title><source> Bioinformatics</source><year>2009</year><volume>25</volume><fpage>465</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">19095700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/btn601</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sen</surname><given-names>TZ</given-names></name><name name-style="western"><surname>Jernigan</surname><given-names>RL</given-names></name><name name-style="western"><surname>Garnier</surname><given-names>J</given-names></name><name name-style="western"><surname>Kloczkowski</surname><given-names>A</given-names></name></person-group><article-title>GOR V server for protein secondary structure prediction</article-title><source> Bioinformatics</source><year>2005</year><volume>21</volume><fpage>2787</fpage><lpage>2788</lpage><pub-id pub-id-type="pmid">15797907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/bti408</pub-id><pub-id pub-id-type="pmcid">PMC2553678</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rost</surname><given-names>B</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>The PredictProtein server</article-title><source> Nucleic Acids Res</source><year>2003</year><volume>31</volume><fpage>3300</fpage><lpage>3304</lpage><pub-id pub-id-type="pmid">12824312</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkg508</pub-id><pub-id pub-id-type="pmcid">PMC168915</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Cottage</surname><given-names>A</given-names></name></person-group><article-title>Bioinformatics methods to predict protein structure and function</article-title><source> A practical approach. Mol Biotechnol</source><year>2003</year><volume>23</volume><fpage>139</fpage><lpage>166</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1385/MB:23:2:139</pub-id><pub-id pub-id-type="pmid">12632698</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiederstein</surname><given-names>M</given-names></name><name name-style="western"><surname>Sippl</surname><given-names>MJ</given-names></name></person-group><article-title>ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins</article-title><source> Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>W407</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">17517781</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkm290</pub-id><pub-id pub-id-type="pmcid">PMC1933241</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laskowski</surname><given-names>RA</given-names></name><name name-style="western"><surname>Rullmannn</surname><given-names>JA</given-names></name><name name-style="western"><surname>MacArthur</surname><given-names>MW</given-names></name><name name-style="western"><surname>Kaptein</surname><given-names>R</given-names></name><name name-style="western"><surname>Thornton</surname><given-names>JM</given-names></name></person-group><article-title>AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR</article-title><source> J Biomol NMR</source><year>1996</year><volume>8</volume><fpage>477</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">9008363</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00228148</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christen</surname><given-names>M</given-names></name><name name-style="western"><surname>Hunenberger</surname><given-names>PH</given-names></name><name name-style="western"><surname>Bakowies</surname><given-names>D</given-names></name><name name-style="western"><surname>Baron</surname><given-names>R</given-names></name><name name-style="western"><surname>Burgi</surname><given-names>R</given-names></name><name name-style="western"><surname>Geerke</surname><given-names>DP</given-names></name><etal/></person-group><article-title>The GROMOS software for biomolecular simulation: GROMOS05</article-title><source> J Comput Chem</source><year>2005</year><volume>26</volume><fpage>1719</fpage><lpage>1751</lpage><pub-id pub-id-type="pmid">16211540</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcc.20303</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ivanciuc</surname><given-names>O</given-names></name><name name-style="western"><surname>Schein</surname><given-names>CH</given-names></name><name name-style="western"><surname>Braun</surname><given-names>W</given-names></name></person-group><article-title>SDAP: database and computational tools for allergenic proteins</article-title><source> Nucleic Acids Res</source><year>2003</year><volume>31</volume><fpage>359</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">12520022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkg010</pub-id><pub-id pub-id-type="pmcid">PMC165457</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuker</surname><given-names>M</given-names></name></person-group><article-title>Mfold web server for nucleic acid folding and hybridization prediction</article-title><source> Nucleic Acids Res</source><year>2003</year><volume>31</volume><fpage>3406</fpage><lpage>3415</lpage><pub-id pub-id-type="pmid">12824337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkg595</pub-id><pub-id pub-id-type="pmcid">PMC169194</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>I-TASSER server for protein 3D structure prediction</article-title><source> BMC Bioinformatics</source><year>2008</year><volume>9</volume><fpage>40</fpage><pub-id pub-id-type="pmid">18215316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2105-9-40</pub-id><pub-id pub-id-type="pmcid">PMC2245901</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rost</surname><given-names>B</given-names></name><name name-style="western"><surname>Sander</surname><given-names>C</given-names></name></person-group><article-title>Conservation and prediction of solvent accessibility in protein families</article-title><source> Proteins</source><year>1994</year><volume>20</volume><fpage>216</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">7892171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/prot.340200303</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Velikovsky</surname><given-names>CA</given-names></name><name name-style="western"><surname>de</surname><given-names>la Barrera S</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>L</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>R</given-names></name><etal/></person-group><article-title>A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B melitensis and B. ovis infection by eliciting a specific cytotoxic response.</article-title><source> Infect Immun</source><year>2005</year><volume>73</volume><fpage>6537</fpage><lpage>6546</lpage><pub-id pub-id-type="pmid">16177328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.73.10.6537-6546.2005</pub-id><pub-id pub-id-type="pmcid">PMC1230944</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delpino</surname><given-names>MV</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Fossati</surname><given-names>CA</given-names></name><name name-style="western"><surname>Baldi</surname><given-names>PC</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name></person-group><article-title>Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice</article-title><source> Vaccine</source><year>2007</year><volume>25</volume><fpage>6721</fpage><lpage>6729</lpage><pub-id pub-id-type="pmid">17686554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2007.07.002</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Mariri</surname><given-names>A</given-names></name></person-group><article-title>Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein</article-title><source> Vaccine</source><year>2010</year><volume>28</volume><fpage>1766</fpage><lpage>1770</lpage><pub-id pub-id-type="pmid">20036752</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2009.12.012</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferbitz</surname><given-names>L</given-names></name><name name-style="western"><surname>Maier</surname><given-names>T</given-names></name><name name-style="western"><surname>Patzelt</surname><given-names>H</given-names></name><name name-style="western"><surname>Bukau</surname><given-names>B</given-names></name><name name-style="western"><surname>Deuerling</surname><given-names>E</given-names></name><name name-style="western"><surname>Ban</surname><given-names>N</given-names></name></person-group><article-title>Trigger factor in complex with the ribosome forms a molecular cradle for nascent proteins</article-title><source> Nature</source><year>2004</year><volume>431</volume><fpage>590</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">15334087</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature02899</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deuerling</surname><given-names>E</given-names></name><name name-style="western"><surname>Patzelt</surname><given-names>H</given-names></name><name name-style="western"><surname>Vorderwulbecke</surname><given-names>S</given-names></name><name name-style="western"><surname>Rauch</surname><given-names>T</given-names></name><name name-style="western"><surname>Kramer</surname><given-names>G</given-names></name><name name-style="western"><surname>Schaffitzel</surname><given-names>E</given-names></name><etal/></person-group><article-title>Trigger factor and DnaK possess overlapping substrate pools and binding specificities</article-title><source> Mol Microbiol</source><year>2003</year><volume>47</volume><fpage>1317</fpage><lpage>1328</lpage><pub-id pub-id-type="pmid">12603737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2958.2003.03370.x</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Debbarh</surname><given-names>HS</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Dubray</surname><given-names>G</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name></person-group><article-title>Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B melitensis Rev.1 vaccinated sheep. </article-title><source>Vet Microbiol</source><year>1996</year><volume>53</volume><fpage>325</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">9008343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-1135(96)01265-5</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seco-Mediavilla</surname><given-names>P</given-names></name><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name><name name-style="western"><surname>Grayon</surname><given-names>M</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Marin</surname><given-names>CM</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis</article-title><source> Clin Diagn Lab Immunol</source><year>2003</year><volume>10</volume><fpage>647</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">12853399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CDLI.10.4.647-651.2003</pub-id><pub-id pub-id-type="pmcid">PMC164270</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Baucheron</surname><given-names>S</given-names></name><name name-style="western"><surname>Vizcaino</surname><given-names>N</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name></person-group><article-title>Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep</article-title><source> Clin Diagn Lab Immunol</source><year>2001</year><volume>8</volume><fpage>772</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">11427425</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CDLI.8.4.772-775.2001</pub-id><pub-id pub-id-type="pmcid">PMC96141</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Vizcaino</surname><given-names>N</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>RA</given-names></name></person-group><article-title>The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice</article-title><source> Microbes Infect</source><year>2003</year><volume>5</volume><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">12650766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1286-4579(02)00075-8</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arai</surname><given-names>R</given-names></name><name name-style="western"><surname>Ueda</surname><given-names>H</given-names></name><name name-style="western"><surname>Kitayama</surname><given-names>A</given-names></name><name name-style="western"><surname>Kamiya</surname><given-names>N</given-names></name><name name-style="western"><surname>Nagamune</surname><given-names>T</given-names></name></person-group><article-title>Design of the linkers which effectively separate domains of a bifunctional fusion protein</article-title><source> Protein Eng</source><year>2001</year><volume>14</volume><fpage>529</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">11579220</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/protein/14.8.529</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>